Company Profile of Boai NKY Pharmaceuticals Ltd.

THE COMPANY

• Publically traded company on the Shenzhen stock exchange (stock code 300109)
• First domestic company to develop and manufacture PVP and PVM/MA products
• 3^rd Largest Global PVP manufacturer
• 2^nd Largest Global PVM/MA manufacturer
• International offices in China, Europe and Japan
• Global distribution network

OUR PRODUCTS

• 12,000 MT/year of PVP capacity
• 2,500 MT/year of PVM/MA capacity
• 12,000 MT/year GBL, 2-pyrrolidone and NVP
• 2,500 MT/year vinyl ethers

QUALITY

• First Chinese manufacturer to be EXCiPACT^TM GMP certified
• All pharmaceutical products manufactured under strict cGMP guidelines
• All pharma products handled and packaged in class D cleanrooms
• State of the art manufacturing facility (commissioned 2013)
• QC equipment and test methods fully validated and fully audit trail compliant

ENVIRONMENTAL RESPONSIBILITY

• Fully compliant with government requirements and regulations
• Real time monitoring of waste streams
• 100% recycling of processing water
• Complete conversion from coal to natural gas
• Focus on developing green production processes

CUSTOMER and TECHNICAL SERVICE

• Technical Research Center to assist our customer with formulation development
• New R&D center commissioned in 2018 having integrated R&D and pilot manufacturing
• Customer partnering to develop new opportunities
• Strong customer and quality management services to assist our customers

NKY® is the registered trademark of Boai NKY Pharmaceuticals Ltd (NKY). KoVidone®, PolyKoVidone® and, OraRez® are the trademark names of NKY.